![Michaël Chassé Profile](https://pbs.twimg.com/profile_images/1858328072052670464/UD2grpN7_x96.jpg)
Michaël Chassé
@Michael_Chasse
Followers
494
Following
298
Statuses
160
Intensivist, Epidemiologist, Centre de recherche du CHUM, Associate Professor, U de Montréal, Scientific Director, CITADEL. Gentleman farmer. Opinions are mine!
Montréal, Canada
Joined November 2009
RT @CritCareReviews: The ninth trial result for #CCR25 in Titanic Belfast in June is the @CCCTG_ INdex Trial CT-perfusion for the Neurolo…
0
4
0
Congratulations to a GREAT! mentor!
“Over my career I’ve dedicated myself to optimizing the #blood products that we give patients and ensuring that they’re safe and effective.” Congratulations Dr. Dean Fergusson on receiving a Lifetime Achievement Award from Canadian Blood Services!
0
0
0
RT @NEJM: Presented at CCR Down Under: In the SAHARA trial involving patients with subarachnoid hemorrhage and anemia, liberal transfusio…
0
24
0
RT @jgordonboyd: Congratulations to @shane_w_english and the rest of the @saharatrial team on publishing this work!
0
3
0
RT @bmj_latest: The BMJ has launched a Commission on the Future of Academic Medicine, which aims to revive academic medicine and redefine i…
0
15
0
RT @kdpsinghlab: When ppl ask me about my priorities as a Chief Health AI Officer, I share the Health AI Paradox. Researched models aren't…
0
46
0
RT @SupportOurSci: #FactFriday Did you know that Canada has the lowest spending on research and development among the #G7, with no increas…
0
91
0
RT @Bram_Rochwerg: ****New Death Determination Guideline**** Developed using comprehensive GRADE methodology. Addressing controversial ar…
0
51
0
@Vadeboncoeur_Al @LussiD @AvecAndreFortin @vmarissal @cdube_sante @joel_arseneau Et il y a encore des soucis d’acceptabilité dans la communauté médicale. Une autre étude que nous avons faite sur le sujet au Canada:
0
0
2
RT @NEJM: Observational evidence is conflicting on whether the sex of blood donors affects recipient outcomes. New findings from a randomiz…
0
19
0
Interesting research question, but the methods used is at least as interesting. We conducted this trial with no manual data collection using @OttawaHospital and @ICES clinical/admin data. @OttawaHospital @CRCHUM
0
5
21
@DrToddLee @MarcCarrier1 @CIHR_ICRH @NEJM @OttMethodsCentr @OttawaHospital But if the question was not about that asymmetric distribution of the estimate but rather about the heterogeneity of treatment effect, well… this is a subgroup. Pre-specified and happens to be on our main exposure, but still a subgroup in a RCT.
0
0
1
@DrToddLee @MarcCarrier1 @CIHR_ICRH @NEJM @OttMethodsCentr @OttawaHospital Thanks for asking! Figure S1 and S2 for unadjusted and adjusted.
1
0
2